CMV Serostatus of Donor-Recipient Pairs Influences the Risk of CMV Infection/Reactivation in HSCT Patients.
about
Controlling cytomegalovirus: helping the immune system take the leadAnti-CMV-IgG positivity of donors is beneficial for alloHSCT recipients with respect to the better short-term immunological recovery and high level of CD4+CD25high lymphocytes.The time is now: moving toward virus-specific T cells after allogeneic hematopoietic stem cell transplantation as the standard of care.The immune response to cytomegalovirus in allogeneic hematopoietic stem cell transplant recipients.Recipient/donor HLA and CMV matching in recipients of T-cell-depleted unrelated donor haematopoietic cell transplants.Sequence homology between HLA-bound cytomegalovirus and human peptides: A potential trigger for alloreactivity.Cytomegalovirus pre-emptive therapy after hematopoietic stem cell transplantation in the era of real-time quantitative PCR: comparison with recipients of solid organ transplants.How Do Donor-Recipient CMV Serostatus and Post-Hematopoietic Stem Cell Transplantation CMV Reactivation Affect Outcomes in Acute Leukemia Patients?
P2860
Q33820695-5D0122FC-EB21-40D3-A3D6-C812E6922FDFQ35232833-E8C2B69D-49D7-4B44-8F29-3A64769D2D6CQ37592177-F61AF03D-0158-4FF5-B0CB-09E4620E0EB5Q38547042-E81B4A45-99EE-4297-BFC7-BDE7A1D31224Q39018399-5B26540C-0ACC-4889-A7D0-BE6A3E2BC318Q40096975-5CE2118D-152C-4C43-B3E7-D31724678BF1Q40721706-E44C320C-4B39-442C-92B7-19DA2F203F82Q42100736-21B75415-2D06-4067-B948-8D4C82AF424F
P2860
CMV Serostatus of Donor-Recipient Pairs Influences the Risk of CMV Infection/Reactivation in HSCT Patients.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
CMV Serostatus of Donor-Recipi ...... Reactivation in HSCT Patients.
@ast
CMV Serostatus of Donor-Recipi ...... Reactivation in HSCT Patients.
@en
type
label
CMV Serostatus of Donor-Recipi ...... Reactivation in HSCT Patients.
@ast
CMV Serostatus of Donor-Recipi ...... Reactivation in HSCT Patients.
@en
prefLabel
CMV Serostatus of Donor-Recipi ...... Reactivation in HSCT Patients.
@ast
CMV Serostatus of Donor-Recipi ...... Reactivation in HSCT Patients.
@en
P2093
P2860
P356
P1433
P1476
CMV Serostatus of Donor-Recipi ...... /Reactivation in HSCT Patients
@en
P2093
Agnieszka Tarnowska
Edyta Kocwin
Jolanta Bochenska
P2860
P304
P356
10.1155/2012/375075
P577
2012-11-22T00:00:00Z